286 results
SD
EX-1.01
PFE
Pfizer Inc.
31 May 24
Conflict minerals disclosure
12:15pm
of “conformant” and “active” smelters and refiners published by the RMI.
3.Design and Implementation of a Strategy to Respond to Risk
A.Based
8-K
EX-99
PFE
Pfizer Inc.
1 May 24
Pfizer Reports First-Quarter 2024 Results
8:11am
, including financial guidance and projections; reorganizations; business plans, strategy, goals and prospects; expectations for our product pipeline
PX14A6G
Tara Health Foundation
16 Apr 24
Letter to shareholders
10:19am
to reproductive health.” The report acknowledges that the Company’s “Board of Directors is actively engaged in the governance and oversight of [its] ESG strategy … upon a more responsible and coherent political spending strategy. Pfizer’s reputation could be at risk, regardless of disclaimers asserting
S-3ASR
xy48fn0nznvxlq2f1
23 Feb 24
Automatic shelf registration
4:34pm
8-K
EX-99
695gnjrtkuikv 1m
30 Jan 24
Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
8:04am
8-K
EX-99.1
87o p7va7mwni302e05
13 Dec 23
Full-Year 2024 Revenue Guidance(1) Range of $58.5 to $61.5 Billion Includes Expected Contribution from Seagen Acquisition
7:44am
8-K
EX-99.1
oymgb
12 Dec 23
Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen
4:35pm
8-K
EX-99
zabgl4ddo99y
31 Oct 23
Pfizer Reports Third-Quarter 2023 Results
8:04am
8-K
EX-99
nu6wnjqym0q50
1 Aug 23
Pfizer Reports Second-Quarter 2023 Results
8:09am
424B5
7pd13aqgqslp1lwdmn5
18 May 23
Prospectus supplement for primary offering
4:37pm
424B3
smk d68290ny
15 May 23
Prospectus supplement
7:50am
POSASR
1fbooqd1 ugqpryvey
15 May 23
Automatic shelf registration (post-effective amendment)
7:40am
8-K
EX-99
rsjdwd 6slik
2 May 23
Pfizer Reports First-Quarter 2023 Results
8:05am
PX14A6G
uzbb8apd
12 Apr 23
Letter to shareholders
9:04am